rolipram has been researched along with Capillary Leak Syndrome in 1 studies
Capillary Leak Syndrome: A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wollborn, J | 1 |
| Siemering, S | 1 |
| Steiger, C | 1 |
| Buerkle, H | 1 |
| Goebel, U | 1 |
| Schick, MA | 1 |
1 other study available for rolipram and Capillary Leak Syndrome
| Article | Year |
|---|---|
Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Cardiac Output; Cardiopulmonary Resuscitat | 2019 |